Medication analysis and pharmaceutical care on a patient with atrial fibrillation and myocardial infarction who developed rhabdomyolysis induced by high-dose atorvastatin and amiodarone

HU Wen-jun; ZHANG Qing-xia

doi:10.3969/j.issn.1672-8157.2020.05.008

Home>Articles>Medication analysis and pharmaceutical care on a patient with atrial fibrillation and myocardial infarction who developed rhabdomyolysis induced by high-dose atorvastatin and amiodarone

DOI: 10.3969/j.issn.1672-8157.2020.05.008

Medication analysis and pharmaceutical care on a patient with atrial fibrillation and myocardial infarction who developed rhabdomyolysis induced by high-dose atorvastatin and amiodarone

HU Wen-jun

ZHANG Qing-xia

Machine-generated Keywords：

Publication Date：2020-10-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 313-316 )

Chinese Journal of Drug Application and Monitoring

ISTIC

ISSN：1672-8157

Year, Vol.(Issue)：2020,17(5)